These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 3143391)
41. [Ways to prevent the calcification of heart valve bioprostheses]. Barbarash LS; Zhuravleva IIu; Medvedeva VM; Shaposhnikov AN Biull Eksp Biol Med; 1988 Dec; 106(12):732-4. PubMed ID: 3207883 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate. Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944 [TBL] [Abstract][Full Text] [Related]
43. A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized trial. Melina G; Rubens MB; Birks EJ; Bizzarri F; Khaghani A; Yacoub MH J Heart Valve Dis; 2000 Jan; 9(1):97-103. PubMed ID: 10678381 [TBL] [Abstract][Full Text] [Related]
44. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification. Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882 [TBL] [Abstract][Full Text] [Related]
45. Amide cross-linking: an alternative to glutaraldehyde fixation. Girardot JM; Girardot MN J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992 [TBL] [Abstract][Full Text] [Related]
46. Fixation-related autolysis and bioprosthetic aortic wall calcification. Human P; Weissenstein C; Trantina A; Zilla P J Heart Valve Dis; 2001 Sep; 10(5):656-65. PubMed ID: 11603606 [TBL] [Abstract][Full Text] [Related]
47. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts. Lee C; Ahn H; Kim SH; Choi SY; Kim YJ Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697 [TBL] [Abstract][Full Text] [Related]
48. Cryopreserved and fresh antibiotic-sterilized valved aortic homograft conduits in a long-term sheep model. Hemodynamic, angiographic, and histologic comparisons. Jonas RA; Ziemer G; Britton L; Armiger LC J Thorac Cardiovasc Surg; 1988 Nov; 96(5):746-55. PubMed ID: 3184968 [TBL] [Abstract][Full Text] [Related]
49. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model. Pettenazzo E; Valente M; Thiene G Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382 [TBL] [Abstract][Full Text] [Related]
50. Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model. Trantina-Yates AE; Human P; Zilla P J Heart Valve Dis; 2003 Jan; 12(1):93-100; discussion 100-1. PubMed ID: 12578343 [TBL] [Abstract][Full Text] [Related]
51. Strategies to mitigate mineralization in the bioprosthetic or homograft cusp and aortic wall. Levy RJ J Heart Valve Dis; 1997 Jan; 6(1):7-8. PubMed ID: 9044069 [No Abstract] [Full Text] [Related]
52. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo. Liu Y; Liu W; Sun G; Wei X; Yi D Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761 [TBL] [Abstract][Full Text] [Related]
53. ADAPT-treated porcine valve tissue (cusp and wall) versus Medtronic Freestyle and Prima Plus: crosslink stability and calcification behavior in the subcutaneous rat model. Neethling WM; Glancy R; Hodge AJ J Heart Valve Dis; 2004 Jul; 13(4):689-96; discussion 696. PubMed ID: 15311879 [TBL] [Abstract][Full Text] [Related]
54. In vivo efficacy for novel combined anticalcification treatment of glutaraldehyde-fixed cardiac xenograft using humanized mice. Lim HG; Choi SY; Jeong S; Shin JS; Park CG; Kim YJ J Biomater Appl; 2015 Feb; 29(7):929-40. PubMed ID: 25245780 [TBL] [Abstract][Full Text] [Related]
55. "Fresh", antibiotic sterilized aortic homografts in extracardiac valved conduits. Long-term results. di Carlo D; de Leval MR; Stark J Thorac Cardiovasc Surg; 1984 Feb; 32(1):10-4. PubMed ID: 6198766 [TBL] [Abstract][Full Text] [Related]
56. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Bailey M; Pillarisetti S; Jones P; Xiao H; Simionescu D; Vyavahare N Cardiovasc Pathol; 2004; 13(3):146-55. PubMed ID: 15081471 [TBL] [Abstract][Full Text] [Related]
57. Kangaroo versus freestyle stentless bioprostheses in a juvenile sheep model: hemodynamic performance and calcification behavior. Neethling WM; Hodge AJ; Glancy R J Card Surg; 2005; 20(1):29-34. PubMed ID: 15673407 [TBL] [Abstract][Full Text] [Related]
58. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. Bando K; Danielson GK; Schaff HV; Mair DD; Julsrud PR; Puga FJ J Thorac Cardiovasc Surg; 1995 Mar; 109(3):509-17; discussion 517-8. PubMed ID: 7877312 [TBL] [Abstract][Full Text] [Related]
59. Role of elastin in pathologic calcification of xenograft heart valves. Bailey MT; Pillarisetti S; Xiao H; Vyavahare NR J Biomed Mater Res A; 2003 Jul; 66(1):93-102. PubMed ID: 12833435 [TBL] [Abstract][Full Text] [Related]
60. Influence of blood contact on the calcification of glutaraldehyde-pretreated porcine aortic valves. Ozaki S; Herijgers P; Flameng W Ann Thorac Cardiovasc Surg; 2003 Aug; 9(4):245-52. PubMed ID: 13129423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]